TilakKumarSundaresanMD

PubMed

• Germline mutations and developmental mosaicism underlying-mutant lung cancer.
  Risa Burr, Ignaty Leshchiner, Christina L Costantino, Martin Blohmer, Tilak Sundaresan, Justin Cha, Karsen Seeger, Sara Guay, Brian P Danysh, Ira Gore, Raquel A Jacobs...> ;Medrxiv. 2023 Sep 29
• 6 citations
  Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
  Ana Babic, Michael H Rosenthal, Tilak K Sundaresan, Natalia Khalaf, Valerie Lee, Lauren K Brais, Maureen Loftus, Leah Caplan, Sarah Denning, Anamol Gurung, Joanna Harr...> ;Nature Communications. 2023 Jul 18
• 6 citations
  Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma.
  Chen Jiang, Zheyang Zhang, Ninah Achacoso, Stacey Alexeeff, Aleyda V Solorzano, Pam Tse, Elaine Chung, Tilak Sundaresan, Jennifer Marie Suga, Sachdev Thomas, Laurel A ...> ;JCO Precision Oncology. 2023 May 1
• 6 citations
  Future of Teleoncology: Trends and Disparities in Telehealth and Secure Message Utilization in the COVID-19 Era.
  Elad Neeman, Liisa Lyon, Hongxin Sun, Carol Conell, Mary Reed, Deepika Kumar, Tatjana Kolevska, Dinesh Kotak, Tilak Sundaresan, Raymond Liu> ;JCO Clinical Cancer Informatics. 2022 Mar 1
• 20 citations
  TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer
  Chen Jiang, Pam Tse, Ninah Achacoso, Stacey E. Alexeeff, Aleyda V Solorzano, Elaine Chung, Wenwei Hu, Thach-Giao Truong, Amit Arora, Tilak Kumar Sundaresan, Jennifer M...> ;Journal of Clinical Oncology. 2021 Nov 29
• 23 citations
  Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages.
  Elad Neeman, Deepika Kumar, Liisa Lyon, Tatjana Kolevska, Mary E. Reed, Tilak Sundaresan, Amit Arora, Yan Li, Samantha A. Seaward, Gillian Kuehner, Sharon Likely, Juli...> ;JAMA Network Open. 2021 Nov 1
• 8 citations
  Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA
  Tilak K. Sundaresan, Taronish D. Dubash, Zongli Zheng, Aditya Bardia, Ben S. Wittner, Nicola Aceto, Erin J. Silva, Douglas B. Fox, Matthew Liebers, Ravi Kapur, John Ia...> ;Breast Cancer Research and Treatment. 2021 Jun 8
• 47 citations
  Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
  Raymond W. Liu, Tilak Sundaresan, Mary E. Reed, Julia R. Trosman, Christine B. Weldon, Tatjana Kolevska> ;JCO Oncology Practice. 2020 May 4
• 9 citations
  Highly Multiplexed Fluorescence in Situ Hybridization for in Situ Genomics
  Maristela L. Onozato, Clarence Yapp, Douglas S. Richardson, Tilak K. Sundaresan, Varun Chahal, Jesse Lee, James P. Sullivan, Marisa W. Madden, Hyo Sup Shim, Mathew Lie...> ;The Journal of Molecular Diagnostics. 2019 May 1
• 21 citations
  Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.
  Ana Babic, Michael H. Rosenthal, William R. Bamlet, Naoki Takahashi, Motokazu Sugimoto, Laura V. Danai, Vicente Morales-Oyarvide, Natalia Khalaf, Richard F. Dunne, Lau...> ;Cancer Epidemiology, Biomarkers & Prevention. 2019 Sep 18
• 122 citations
  Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.
  Benjamin J. Drapkin, Julie George, Camilla L. Christensen, Mari Mino-Kenudson, Ruben Dries, Tilak K. Sundaresan, Sarah Phat, David T. Myers, Jun Zhong, Peter Igo, Mehl...> ;Cancer Discovery. 2018 Feb 26
• 82 citations
  Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition
  , , , , , , , , , , , , , , , , , , , , , > ;Cell Reports. 2016 Dec 6
• 15 citations
  Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Ho...
  Aditya Bardia, John Iafrate, Tilak K. Sundaresan, Jerry Younger, Valentina Nardi> ;The Oncologist. 2016 Sep 1
• 4 citations
  Fantastic voyage: the future of cancer diagnostics
  Tilak K. Sundaresan, Daniel A. Haber> ;The Lancet. Oncology. 2015 Dec 1
• 283 citations
  Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
  Tilak K. Sundaresan, Lecia V. Sequist, John V. Heymach, Gregory J. Riely, Pasi A. Jänne, Walter H. Koch, James P. Sullivan, Douglas B. Fox, Robert C. Maher, Alona Muzi...> ;Clinical Cancer Research. 2016 Mar 1
• 4 citations
  Does molecular monitoring matter in early-stage breast cancer?
  Tilak K. Sundaresan, Daniel A. Haber> ;Science Translational Medicine. 2015 Aug 26
• 454 citations
  A microfluidic device for label-free, physical capture of circulating tumor cell clusters
  A. Fatih Sarioglu, Nicola Aceto, Nikola Kojic, Maria C. Donaldson, Mahnaz Zeinali, Bashar Hamza, Amanda Engstrom, Huili Zhu, Tilak K. Sundaresan, David T. Miyamoto, Xi...> ;Nature Methods. 2015 Jul 1
• 95 citations
  Notch-1 regulates transcription of the epidermal growth factor receptor through p53
  Benjamin Purow, Tilak K. Sundaresan, Michael J. Burdick, Benjamin Kefas, Laurey Comeau, Michael P. Hawkinson, Qin Su, Yuri Kotliarov, Jeongwu Lee, Wei Zhang, Howard A....> ;Carcinogenesis. 2008 May 1
• 445 citations
  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.
  Benjamin Purow, Raqeeb M. Haque, Martha Noel, Qin Su, Michael J. Burdick, Jeongwu Lee, Tilak K. Sundaresan, Sandra Pastorino, John K. Park, Irina Mikolaenko, Dragan Ma...> ;Cancer Research. 2005 Mar 15
• Join now to see all